pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-3607 |
Genomic Coordinates | chr5: 86620497 - 86620575 |
Description | Homo sapiens miR-3607 stem-loop |
Comment | None |
RNA Secondary Structure |
Mature miRNA Information | |
---|---|
Mature miRNA | hsa-miR-3607-3p |
Sequence | 51| ACUGUAAACGCUUUCUGAUG |70 |
Evidence | Experimental |
Experiments | Illumina |
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
miRNAs in Extracellular Vesicles |
|
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | TRIM59 | ||||||||||||||||||||
Synonyms | IFT80L, MRF1, RNF104, TRIM57, TSBF1 | ||||||||||||||||||||
Description | tripartite motif containing 59 | ||||||||||||||||||||
Transcript | NM_173084 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on TRIM59 | |||||||||||||||||||||
3'UTR of TRIM59 (miRNA target sites are highlighted) |
>TRIM59|NM_173084|3'UTR 1 AAATGTCAACCTGAATTGTTTAAATGGGCTTATTCTGTACATTGCTAAACAAAAAATGGGGTAGCATGGATAAAGAGCAA 81 ACTAAGCTTTATTAGTGCTGCAACTAATATAAACAAATGTTTATATTTGTTGCTTCTTTTGGTTAGCAATGATATGTCAA 161 AGTTATATCTGAAATAGTCAAATCTTTGGGAAACAGAATCTAGTAACAATTTGAAAAGTAATACACTATCCCATTTTTAT 241 TGGCTTTATGATGGTTGACATAATGTTGCTGTGACATTTAAACATTCTTGTACCAATATTGTCTTTTACCATTATTATAT 321 ACTGCAGTTAATTGGCTTTACAGTTCTTTATATATATAGCAAAATCCTGAAAGAACATATACCTTTATTTTGATGTGGCT 401 TGAAGCTTTTGAATGGGTGAATAAGGATGATAGAAAGGTTTCAAAATCAAGCAACAAAGTCTTAAAGTGATAAGGCATGG 481 CTTAAAGATCTTTTGATCAAACATACCTGTGTTTGAGATAGATTTAAGAGCCCTAAATGCTTATCACCATTCACTCCAAA 561 TAAAACTATTGCTTTTGGATAACTGTTAGAGTAAAGTGGCTTTTTAAAAGAAATTTTTGAGACTGGGTCTCACCTTGTTG 641 CCCAGGCTGGAGTGTAGTTGTCTGGTCATGACTCACTGCAGTTTCGACCACCCAGGCTCAATCGATCCTCCCGCCTCTGC 721 CTCTGGAGCAGCTGGGACAAGGCACACACCCCCATGCCTGGCTAATTAAAAAAATTGTTTTTTGTAGAAACGAGGTTTTG 801 CCATATTGCCCAGGTTGGTCTCAAACTTCTGGGCTCAAGAGATCTGCCCACCTTGGCCTCCCAAAGTGCTGGGATTACAG 881 ACGTTAGCCACACTGTGCCTGGGGGCCAGCATTTTCTAATACTTGTCATATTCTATAGTTTGTGCAAATTTAAGATTGTT 961 TTTTTTTCTGCTCGTCAGTCAAATCAGTTCTTGGATTAAAAACTCATTCTTATTAGAACAGAATCATGTTGGTAACTTGG 1041 TCTGCAACAGGTTTTGATGGCATCATGTGGACTTTATTCATCTTAACTCATTTAAATTTTCTACCACATTCCCTTAAGCT 1121 AATGCAAAAGTACCAACAACTTAATCTTTTTTTTTTTTTTTTTTTTTTTTTTTTGAGACGGAGTCTTGCTCTGTCGCCCA 1201 GGCTGGAGTGCAGTGGCGTGATCTCGGCTCATTGCAAGCCCCGCCTCCCGGGTTCACACCATTCTCCTGCCTCAGCCTCC 1281 CGAGTAGCTGGGACTACAGGCATCTGCTACCACGCCCAGCTAATTTTCTGTATTTTTAGTAGAGATGGGGTTTCACTGTG 1361 TTAGCCAGGATGGTCTCTATCTCCTGACCTCATGATCCACTCGCCTCAGCCTCCCAAAATGCTGGGATTATAGGCGTGAG 1441 CCGCCACGCCCGGCCCAACAACTTAATCTTTTATTAGCTTTGCTTAAGAGGGCCAATTAAATCAAAGCCCTTTAGTTCCC 1521 TTTAACAGGGACTGGAGTTATGATGCATGTGTTACGACTTTTGGCCCACTGTCCATGCAACTCTAAGTGCAGGTTGATTT 1601 GCTTTCCAGAAATCCCAAAGGGGCTGCTCTTGGATCACCGAAGAGCCTTACCTATATCAAATCAAAAAGACATTCTGGGT 1681 CAGATTAGACTATGCTCCTGGCCCTACAGATTGCACATAAACTATCATAAATACAGCTTTTTCAGGGAACTAGTTCTAAA 1761 ACTCTTACCTGCTGAGAATAAGTCTTAACACTAAGATGACTGTATTATATCAATTTATTATTAGAATCAGACTTATACCT 1841 AGCACAATTAACTATTGTGTGGGCAAAGAACATTTAAAGGGCATAGTAGAGGTAAGGAGAGACACATACTCAGCTAGAGA 1921 TAAAAATACTAAGTTGCACTGATTACTTAAAATACTAGTCACACCATAAAAGTGCCCTGTAGTTTCAAAAACACGTAAGC 2001 AATGAAATGTTAGCCATTATGTGTTAAACTACTTAATCTCATTTCTGTGATGTGAATATTTTTAACCCCCTTTTTGTAGA 2081 TGAGGGAACTGACAAGTGACTTGTCCAAGGCCATATAGCTGTGAGAAAACCCATGCATTCTCTTTTCAGAGTTCATGCTA 2161 TCACTCAACTTTAAAGTAGGCCAAGATTAATGTTGGTAAGGGTTTGTAATCTGTAAGAATGCTAAAAACGTAAGTATATA 2241 TATCATTTTAGATTTGACATTTTGTATCTTGCCAGTTTTTAGGAGAACTTTTCATTTTGTTAAGTATGCATGAATATAGT 2321 TGAGTATATGAGTAACTGGTTCTTATGCTGCTGTTTTGTATTTTTACCAGCAGGAAGATTGCAAAAGTTGATGTATGTAA 2401 ATCTTGAAATATTTCTAAGTTTTATGTATAACAAAATATGTATTTTAATAAACTTCTTTTGATATTTTAAAAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | BC-3 | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM796039. RNA binding protein: AGO2. Condition:4-Thiouridine
PAR-CLIP data was present in GSM796040. RNA binding protein: AGO2. Condition:4-Thiouridine
... - Gottwein E; Corcoran DL; Mukherjee N; et al., 2011, Cell host & microbe. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Gottwein E; Corcoran DL; Mukherjee N; et al. - Cell host & microbe, 2011
Primary effusion lymphoma (PEL) is caused by Kaposi's sarcoma-associated herpesvirus (KSHV) and frequently also harbors Epstein-Barr virus (EBV). The expression of KSHV- and EBV-encoded microRNAs (miRNAs) in PELs suggests a role for these miRNAs in latency and lymphomagenesis. Using PAR-CLIP, a technology which allows the direct and transcriptome-wide identification of miRNA targets, we delineate the target sites for all viral and cellular miRNAs expressed in PEL cell lines. The resulting data set revealed that KSHV miRNAs directly target more than 2000 cellular mRNAs, including many involved in pathways relevant to KSHV pathogenesis. Moreover, 58% of these mRNAs are also targeted by EBV miRNAs, via distinct binding sites. In addition to a known viral analog of cellular miR-155, we show that KSHV encodes a viral miRNA that mimics cellular miR-142-3p function. In summary, this study identifies an extensive list of KSHV miRNA targets, which are likely to influence viral replication and pathogenesis.
LinkOut: [PMID: 22100165]
|
Experimental Support 2 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | EF3D-AGO2 , LCL-BAC |
Disease | MIMAT0017985 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
"PAR-CLIP data was present in GSM1020021. RNA binding protein: AGO2. Condition:EBV B95-8-infected
"PAR-CLIP data was present in GSM1020023. RNA binding protein: AGO2. Condition:EBV B95-8-infected
... - Skalsky RL; Corcoran DL; Gottwein E; Frank et al., 2012, PLoS pathogens. |
Article |
- Skalsky RL; Corcoran DL; Gottwein E; Frank et al. - PLoS pathogens, 2012
Epstein-Barr virus (EBV) is a ubiquitous human herpesvirus linked to a number of B cell cancers and lymphoproliferative disorders. During latent infection, EBV expresses 25 viral pre-microRNAs (miRNAs) and induces the expression of specific host miRNAs, such as miR-155 and miR-21, which potentially play a role in viral oncogenesis. To date, only a limited number of EBV miRNA targets have been identified; thus, the role of EBV miRNAs in viral pathogenesis and/or lymphomagenesis is not well defined. Here, we used photoactivatable ribonucleoside-enhanced crosslinking and immunoprecipitation (PAR-CLIP) combined with deep sequencing and computational analysis to comprehensively examine the viral and cellular miRNA targetome in EBV strain B95-8-infected lymphoblastoid cell lines (LCLs). We identified 7,827 miRNA-interaction sites in 3,492 cellular 3'UTRs. 531 of these sites contained seed matches to viral miRNAs. 24 PAR-CLIP-identified miRNA:3'UTR interactions were confirmed by reporter assays. Our results reveal that EBV miRNAs predominantly target cellular transcripts during latent infection, thereby manipulating the host environment. Furthermore, targets of EBV miRNAs are involved in multiple cellular processes that are directly relevant to viral infection, including innate immunity, cell survival, and cell proliferation. Finally, we present evidence that myc-regulated host miRNAs from the miR-17/92 cluster can regulate latent viral gene expression. This comprehensive survey of the miRNA targetome in EBV-infected B cells represents a key step towards defining the functions of EBV-encoded miRNAs, and potentially, identifying novel therapeutic targets for EBV-associated malignancies.
LinkOut: [PMID: 22291592]
|
CLIP-seq Support 1 for dataset GSM4903829 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Human neurons / CTLTD_shCTL_a |
Location of target site | NM_173084 | 3UTR | UGCCCACCUUGGCCUCCCAAAGUGCUGGGAUUACAG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161238 |
CLIP-seq Viewer | Link |
CLIP-seq Support 2 for dataset GSM4903833 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / CTL_TD_21_a |
Location of target site | NM_173084 | 3UTR | CUCAAGAGAUCUGCCCACCUUGGCCUCCCAAAGUGCUGGGAUUACAG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 3 for dataset GSM4903834 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / CTL_TD_21_b |
Location of target site | NM_173084 | 3UTR | UCAAGAGAUCUGCCCACCUUGGCCUCCCAAAGUGCUGGGAUUACAG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 4 for dataset GSM4903835 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / CTL_TD_21_c |
Location of target site | NM_173084 | 3UTR | CUCAAGAGAUCUGCCCACCUUGGCCUCCCAAAGUGCUGGGAUUACAG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 5 for dataset GSM4903836 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / 124_TD_21_a |
Location of target site | NM_173084 | 3UTR | CUCAAGAGAUCUGCCCACCUUGGCCUCCCAAAGUGCUGGGAUUACAG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 6 for dataset GSM4903837 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / 124_TD_21_b |
Location of target site | NM_173084 | 3UTR | UCAAGAGAUCUGCCCACCUUGGCCUCCCAAAGUGCUGGGAUUACAG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 7 for dataset GSM4903838 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / 124_TD_21_c |
Location of target site | NM_173084 | 3UTR | CUCAAGAGAUCUGCCCACCUUGGCCUCCCAAAGUGCUGGGAUUACAG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 8 for dataset GSM1020021 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | EF3D-AGO2 / EBV B95-8-infected, 4-thiouridine, RNase T1 |
Location of target site | ENST00000309784.4 | 3UTR | UUGGCUUUACAGUUCU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 22291592 / GSE41437 |
CLIP-seq Viewer | Link |
CLIP-seq Support 9 for dataset GSM1020023 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | LCL-BAC / EBV B95-8-infected, 4-thiouridine, RNase T1 |
Location of target site | ENST00000309784.4 | 3UTR | UUGGCUUUACAGUUCU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 22291592 / GSE41437 |
CLIP-seq Viewer | Link |
CLIP-seq Support 10 for dataset GSM796039 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | BC-3 / 4-Thiouridine |
Location of target site | ENST00000309784.4 | 3UTR | UUGGCUUUACAGUUCU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 22100165 / GSE32109 |
CLIP-seq Viewer | Link |
CLIP-seq Support 11 for dataset GSM796040 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | BC-3 / 4-Thiouridine |
Location of target site | ENST00000309784.4 | 3UTR | UUGGCUUUACAGUUC |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 22100165 / GSE32109 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
93 hsa-miR-3607-3p Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT057680 | LCOR | ligand dependent nuclear receptor corepressor | 2 | 2 | ||||||||
MIRT058092 | EIF4G2 | eukaryotic translation initiation factor 4 gamma 2 | 2 | 4 | ||||||||
MIRT063624 | FBXO28 | F-box protein 28 | 2 | 2 | ||||||||
MIRT071884 | BTF3L4 | basic transcription factor 3 like 4 | 2 | 2 | ||||||||
MIRT079440 | FOXK2 | forkhead box K2 | 2 | 4 | ||||||||
MIRT080491 | BCL10 | B-cell CLL/lymphoma 10 | 2 | 2 | ||||||||
MIRT081214 | MIDN | midnolin | 2 | 10 | ||||||||
MIRT082786 | ZNF264 | zinc finger protein 264 | 2 | 2 | ||||||||
MIRT082862 | ZNF543 | zinc finger protein 543 | 2 | 4 | ||||||||
MIRT099112 | FOXC1 | forkhead box C1 | 2 | 4 | ||||||||
MIRT099343 | QKI | QKI, KH domain containing RNA binding | 2 | 2 | ||||||||
MIRT100913 | CD2AP | CD2 associated protein | 2 | 2 | ||||||||
MIRT104030 | USP42 | ubiquitin specific peptidase 42 | 2 | 6 | ||||||||
MIRT130023 | QSER1 | glutamine and serine rich 1 | 2 | 2 | ||||||||
MIRT142614 | IL21R | interleukin 21 receptor | 2 | 2 | ||||||||
MIRT143477 | CHD9 | chromodomain helicase DNA binding protein 9 | 2 | 2 | ||||||||
MIRT187759 | ESYT1 | extended synaptotagmin 1 | 2 | 2 | ||||||||
MIRT200250 | EVI5 | ecotropic viral integration site 5 | 2 | 2 | ||||||||
MIRT212867 | N4BP2 | NEDD4 binding protein 2 | 2 | 2 | ||||||||
MIRT219622 | GIGYF1 | GRB10 interacting GYF protein 1 | 2 | 8 | ||||||||
MIRT220244 | FAM3C | family with sequence similarity 3 member C | 2 | 6 | ||||||||
MIRT222069 | PURB | purine rich element binding protein B | 2 | 2 | ||||||||
MIRT243478 | TRIM71 | tripartite motif containing 71 | 2 | 2 | ||||||||
MIRT261690 | PLEKHA1 | pleckstrin homology domain containing A1 | 2 | 2 | ||||||||
MIRT320184 | ITGB8 | integrin subunit beta 8 | 2 | 2 | ||||||||
MIRT441644 | CCNB1IP1 | cyclin B1 interacting protein 1 | 2 | 6 | ||||||||
MIRT441965 | BACE2 | beta-site APP-cleaving enzyme 2 | 2 | 2 | ||||||||
MIRT442175 | TRIM59 | tripartite motif containing 59 | 2 | 4 | ||||||||
MIRT442716 | TNKS | tankyrase | 2 | 2 | ||||||||
MIRT443932 | ZNF418 | zinc finger protein 418 | 2 | 2 | ||||||||
MIRT445790 | ALG13 | ALG13, UDP-N-acetylglucosaminyltransferase subunit | 2 | 2 | ||||||||
MIRT448148 | P2RY10 | purinergic receptor P2Y10 | 2 | 2 | ||||||||
MIRT463393 | ZDHHC20 | zinc finger DHHC-type containing 20 | 2 | 2 | ||||||||
MIRT463761 | YPEL2 | yippee like 2 | 2 | 2 | ||||||||
MIRT477233 | ETF1 | eukaryotic translation termination factor 1 | 2 | 2 | ||||||||
MIRT483464 | DR1 | down-regulator of transcription 1 | 2 | 6 | ||||||||
MIRT484110 | ABCD2 | ATP binding cassette subfamily D member 2 | 2 | 4 | ||||||||
MIRT487297 | SLC38A9 | solute carrier family 38 member 9 | 2 | 2 | ||||||||
MIRT501292 | RRN3 | RRN3 homolog, RNA polymerase I transcription factor | 2 | 4 | ||||||||
MIRT501343 | RNF44 | ring finger protein 44 | 2 | 4 | ||||||||
MIRT502696 | CSNK1G1 | casein kinase 1 gamma 1 | 2 | 4 | ||||||||
MIRT511075 | NIPA1 | non imprinted in Prader-Willi/Angelman syndrome 1 | 2 | 4 | ||||||||
MIRT511243 | KLHL36 | kelch like family member 36 | 2 | 6 | ||||||||
MIRT531418 | PLBD2 | phospholipase B domain containing 2 | 2 | 2 | ||||||||
MIRT536603 | IRF2 | interferon regulatory factor 2 | 2 | 2 | ||||||||
MIRT537727 | ELAVL2 | ELAV like RNA binding protein 2 | 2 | 2 | ||||||||
MIRT537985 | DPP8 | dipeptidyl peptidase 8 | 2 | 2 | ||||||||
MIRT539083 | ARNTL | aryl hydrocarbon receptor nuclear translocator like | 2 | 4 | ||||||||
MIRT547185 | PBRM1 | polybromo 1 | 2 | 2 | ||||||||
MIRT547596 | LIN28B | lin-28 homolog B | 2 | 2 | ||||||||
MIRT548188 | FOXA1 | forkhead box A1 | 2 | 2 | ||||||||
MIRT555055 | PYURF | PIGY upstream reading frame | 2 | 2 | ||||||||
MIRT557321 | HIC2 | HIC ZBTB transcriptional repressor 2 | 2 | 2 | ||||||||
MIRT557979 | FAM217B | family with sequence similarity 217 member B | 2 | 4 | ||||||||
MIRT558439 | DDIT4 | DNA damage inducible transcript 4 | 2 | 3 | ||||||||
MIRT558560 | CRLF3 | cytokine receptor like factor 3 | 2 | 4 | ||||||||
MIRT562332 | FGF2 | fibroblast growth factor 2 | 2 | 2 | ||||||||
MIRT565836 | SCML2 | Scm polycomb group protein like 2 | 2 | 2 | ||||||||
MIRT566796 | MIER3 | MIER family member 3 | 2 | 2 | ||||||||
MIRT568565 | AK4 | adenylate kinase 4 | 2 | 2 | ||||||||
MIRT572483 | PRR14L | proline rich 14 like | 2 | 2 | ||||||||
MIRT572586 | HGFAC | HGF activator | 2 | 2 | ||||||||
MIRT572876 | OPHN1 | oligophrenin 1 | 2 | 2 | ||||||||
MIRT573136 | ABT1 | activator of basal transcription 1 | 2 | 2 | ||||||||
MIRT573244 | ZBTB46 | zinc finger and BTB domain containing 46 | 2 | 2 | ||||||||
MIRT573388 | GGA2 | golgi associated, gamma adaptin ear containing, ARF binding protein 2 | 2 | 2 | ||||||||
MIRT574588 | N4BP1 | NEDD4 binding protein 1 | 2 | 2 | ||||||||
MIRT575081 | Ddit4 | DNA-damage-inducible transcript 4 | 2 | 3 | ||||||||
MIRT609077 | SMIM15 | small integral membrane protein 15 | 2 | 8 | ||||||||
MIRT619337 | RNF2 | ring finger protein 2 | 2 | 2 | ||||||||
MIRT623058 | NRXN1 | neurexin 1 | 2 | 2 | ||||||||
MIRT623307 | MARCH4 | membrane associated ring-CH-type finger 4 | 2 | 2 | ||||||||
MIRT623899 | FOXN3 | forkhead box N3 | 2 | 2 | ||||||||
MIRT625177 | GRIK4 | glutamate ionotropic receptor kainate type subunit 4 | 2 | 2 | ||||||||
MIRT630448 | GTPBP8 | GTP binding protein 8 (putative) | 2 | 2 | ||||||||
MIRT630587 | SLC9A8 | solute carrier family 9 member A8 | 2 | 2 | ||||||||
MIRT634451 | PAK6 | p21 (RAC1) activated kinase 6 | 2 | 2 | ||||||||
MIRT634727 | CYP20A1 | cytochrome P450 family 20 subfamily A member 1 | 2 | 2 | ||||||||
MIRT635769 | PDCL3 | phosducin like 3 | 2 | 2 | ||||||||
MIRT650924 | ST6GALNAC1 | ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 1 | 2 | 2 | ||||||||
MIRT668975 | CLSTN2 | calsyntenin 2 | 2 | 2 | ||||||||
MIRT669612 | AEBP2 | AE binding protein 2 | 2 | 2 | ||||||||
MIRT686746 | STX16 | syntaxin 16 | 2 | 2 | ||||||||
MIRT687932 | HMGN1 | high mobility group nucleosome binding domain 1 | 2 | 2 | ||||||||
MIRT691875 | GXYLT2 | glucoside xylosyltransferase 2 | 2 | 2 | ||||||||
MIRT698432 | TM4SF1 | transmembrane 4 L six family member 1 | 2 | 2 | ||||||||
MIRT698572 | TFDP2 | transcription factor Dp-2 | 2 | 2 | ||||||||
MIRT704500 | CPEB4 | cytoplasmic polyadenylation element binding protein 4 | 2 | 2 | ||||||||
MIRT704907 | CCDC71L | coiled-coil domain containing 71 like | 2 | 2 | ||||||||
MIRT713810 | XRCC2 | X-ray repair cross complementing 2 | 2 | 2 | ||||||||
MIRT718300 | MOGAT1 | monoacylglycerol O-acyltransferase 1 | 2 | 2 | ||||||||
MIRT719022 | SHROOM3 | shroom family member 3 | 2 | 2 | ||||||||
MIRT723766 | MPLKIP | M-phase specific PLK1 interacting protein | 2 | 2 |
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|